Trademark: 90300948
Word
BREYANZI
Status
Registered
Status Code
700
Status Date
Tuesday, September 20, 2022
Serial Number
90300948
Registration Number
6853222
Registration Date
Tuesday, September 20, 2022
Mark Type
3000
Filing Date
Thursday, November 5, 2020
Published for Opposition
Tuesday, November 23, 2021

Trademark Owner History
JUNO THERAPEUTICS, INC. - Original Registrant

Classifications
44 Medical treatment of cancer, lymphoma; provision of information and data for diagnosis and medical treatment
The mark consists of "BREYANZI" in dark blue font with an orange dot over the "I" with a sunburst design behind and above the "ZI" with half of the dots in the upper side in dark blue dots and the other half of the dots in the lower side in light blue dots.
The color(s) dark blue, light blue, and orange is/are claimed as a feature of the mark.

Trademark Events
Sep 20, 2022
Notice Of Registration Confirmation Emailed
Sep 20, 2022
Registered-Principal Register
Aug 17, 2022
Notice Of Acceptance Of Statement Of Use E-Mailed
Aug 16, 2022
Allowed Principal Register - Sou Accepted
Jul 30, 2022
Statement Of Use Processing Complete
Jul 12, 2022
Use Amendment Filed
Jul 28, 2022
Case Assigned To Intent To Use Paralegal
Jul 12, 2022
Teas Statement Of Use Received
Jan 18, 2022
Noa E-Mailed - Sou Required From Applicant
Nov 23, 2021
Official Gazette Publication Confirmation E-Mailed
Nov 23, 2021
Published For Opposition
Nov 3, 2021
Notification Of Notice Of Publication E-Mailed
Oct 21, 2021
Approved For Pub - Principal Register
Oct 20, 2021
Teas/Email Correspondence Entered
Oct 19, 2021
Correspondence Received In Law Office
Oct 19, 2021
Teas Response To Office Action Received
Apr 19, 2021
Notification Of Non-Final Action E-Mailed
Apr 19, 2021
Non-Final Action E-Mailed
Apr 19, 2021
Non-Final Action Written
Apr 12, 2021
Assigned To Examiner
Jan 6, 2021
Notice Of Design Search Code E-Mailed
Jan 5, 2021
New Application Office Supplied Data Entered In Tram
Nov 9, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24